Background pattern
WEGOVY 0.5 mg FLEXTOUCH PRE-FILLED PEN INJECTABLE SOLUTION

WEGOVY 0.5 mg FLEXTOUCH PRE-FILLED PEN INJECTABLE SOLUTION

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use WEGOVY 0.5 mg FLEXTOUCH PRE-FILLED PEN INJECTABLE SOLUTION

Introduction

Package Leaflet: Information for the Patient

Wegovy 0.25mg FlexTouch solution for injection in pre-filled pen

Wegovy 0.5mg FlexTouch solution for injection in pre-filled pen

Wegovy 1mg FlexTouch solution for injection in pre-filled pen

Wegovy 1.7mg FlexTouch solution for injection in pre-filled pen

Wegovy 2.4mg FlexTouch solution for injection in pre-filled pen

semaglutide

This medicine is subject to additional monitoring, which will allow for quick identification of new safety information. You can help by reporting any side effects you may get. The last section of this leaflet includes information on how to report side effects.

Read all of this leaflet carefully before you start using this medicine, because it contains important information for you.

  • Keep this leaflet, you may need to read it again.
  • If you have any further questions, ask your doctor, pharmacist, or nurse.
  • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
  • If you get any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in this leaflet. See section 4.

Contents of the pack

  1. What is Wegovy and what is it used for
  2. What you need to know before you use Wegovy
  3. How to use Wegovy
  4. Possible side effects
  5. Storage of Wegovy
  6. Contents of the pack and other information

1. What is Wegovy and what is it used for

What is Wegovy

Wegovy is a medicine for weight loss and weight maintenance that contains the active substance semaglutide. It is similar to a naturally occurring hormone called glucagon-like peptide-1 (GLP-1) that is released from the intestine after eating. It works by acting on areas (receptors) of the brain that control appetite, making you feel fuller and less hungry, and experiencing less desire to eat. This will help you eat fewer calories and reduce body weight. Wegovy may also help prevent heart disease.

What Wegovy is used for

Wegovy is used together with diet and physical activity to lose weight and help keep weight under control. It is used in adults who have

  • a BMI of 30 kg/m² or higher (obesity) or
  • a BMI of at least 27 kg/m², but less than 30 kg/m² (overweight) who have health problems related to weight (such as diabetes, high blood pressure, abnormal blood fats, breathing problems during sleep called "obstructive sleep apnea" or a history of heart attack, stroke, or vascular problems).

Body Mass Index (BMI) is a measure of weight in relation to height.

Wegovy is used together with diet and physical activity for weight control in adolescents aged 12 years and older with

  • obesity and
  • body weight >60 kg.

As an adolescent patient, you should only continue using Wegovy if you have lost at least 5% of your BMI after 12 weeks of treatment with the 2.4 mg dose or the maximum tolerated dose (see section 3). Consult your doctor before continuing.

2. What you need to know before you use Wegovy

Do not use Wegovy

  • if you are allergic to semaglutide or any of the other ingredients of this medicine (listed in section 6).

Warnings and precautions

Talk to your doctor, pharmacist, or nurse before you start using Wegovy.

Wegovy should not be used if:

  • you use other products for weight loss,
  • you have type 1 diabetes,
  • you have severely reduced kidney function,
  • you have severely reduced liver function,
  • you have severe heart failure,
  • you have diabetic eye disease (retinopathy).

There is limited experience with Wegovy in patients:

  • 85 years of age or older,
  • with liver problems,
  • with severe stomach or intestinal problems that cause delayed emptying of the stomach (called gastroparesis) or if you have any inflammatory bowel disease.

Talk to your doctor if you are in any of these situations.

If you know you are going to have surgery where you will be under anesthesia (sleep), tell your doctor that you are taking Wegovy.

  • Dehydration

During treatment with Wegovy, you may have nausea, vomiting, or diarrhea. These side effects can cause dehydration (loss of fluids). It is important to drink enough fluids to prevent dehydration. This is especially important if you have kidney problems. If you have any doubts or concerns, talk to your doctor.

  • Pancreatitis

If you have severe and persistent stomach pain (see section 4), go to the doctor immediately, as it could be a symptom of pancreatitis (acute pancreatitis).

  • People with type 2 diabetes

Wegovy cannot be used as a substitute for insulin. Do not use Wegovy in combination with other medicines that contain GLP-1 receptor agonists (such as liraglutide, dulaglutide, exenatide, or lixisenatide).

  • Low blood sugar (hypoglycemia)

Taking a sulfonylurea or insulin with Wegovy may increase the risk of experiencing low blood sugar (hypoglycemia). To know the warning signs of low blood sugar, see section 4. Your doctor may ask you to measure your blood sugar levels. This will help your doctor decide if it is necessary to change the dose of sulfonylurea or insulin to reduce the risk of low blood sugar.

  • Diabetic eye disease (retinopathy)

If you have diabetic eye disease and are using insulin, this medicine may cause your vision to worsen and you may need treatment. Sudden improvements in blood sugar control can cause a temporary worsening of diabetic eye disease. Tell your doctor if you have diabetic eye disease and experience eye problems while taking this medicine.

Children and adolescents

The safety and efficacy of Wegovy in children under 12 years of age have not been studied, and its use is not recommended in this population.

Other medicines and Wegovy

Tell your doctor, pharmacist, or nurse if you are using, have recently used, or might use any other medicines.

In particular, tell your doctor, pharmacist, or nurse if you are using medicines that contain:

  • warfarin or other similar medicines taken by mouth to reduce blood clotting (oral anticoagulants). When you start treatment, for example, with warfarin or similar medicines, you may need to have frequent blood tests to determine your blood clotting ability.

Pregnancy and breastfeeding

This medicine should not be used during pregnancy, as it is not known if it can affect the fetus. Therefore, it is recommended to use contraceptive methods during the use of this medicine. If you wish to become pregnant, you should stop using this medicine at least 2 months in advance. If you become pregnant, think you may be pregnant, or plan to become pregnant while using this medicine, talk to your doctor immediately, as you should stop treatment.

Do not use this medicine during breastfeeding, as it is not known if it is excreted in breast milk.

Driving and using machines

Wegovy is unlikely to affect your ability to drive or use machines. Some patients may feel dizzy when using Wegovy, mainly during the first 4 months of treatment (see section 4). If you feel dizzy, be extra careful when driving or using machines. If you need more information, talk to your doctor, pharmacist, or nurse.

People with type 2 diabetes

If you use this medicine in combination with a sulfonylurea or insulin, you may experience low blood sugar (hypoglycemia), which can reduce your ability to concentrate. Avoid driving or using machines if you experience any symptoms of low blood sugar. See section 2, "Warnings and precautions" for information on the increased risk of low blood sugar and section 4 to know the warning signs of low blood sugar. For more information, talk to your doctor.

Wegovy contains sodium

This medicine contains less than 1 mmol of sodium (23 mg) per dose; it is essentially "sodium-free".

3. How to use Wegovy

Follow the instructions for administration given by your doctor exactly. If you are in doubt, talk to your doctor, pharmacist, or nurse again.

How much to use

Adults

The recommended dose is 2.4 mg once a week.

Treatment will start with a low dose that will be gradually increased over 16 weeks of treatment.

  • When you start using Wegovy, the starting dose is 0.25 mg once a week.
  • Your doctor will tell you to gradually increase the dose every 4 weeks until you reach the recommended dose of 2.4 mg once a week.
  • Once you reach the recommended dose of 2.4 mg, do not increase the dose further.
  • If you feel very bothered by nausea or vomiting, talk to your doctor about the possibility of delaying the dose escalation or going back to the previous dose until the symptoms have improved.

Normally, you will be told to follow the following table.

Dose escalation

Weekly dose

Week 1 to 4

0.25 mg

Week 5 to 8

0.5 mg

Week 9 to 12

1 mg

Week 13 to 16

1.7 mg

From week 17

2.4 mg

Your doctor will regularly assess your treatment.

Adolescents (12 years and older)

For adolescents, the same dose escalation schedule should be applied as for adults (see above). The dose should be increased to 2.4 mg (maintenance dose) or to the maximum tolerated dose. Weekly doses above 2.4 mg are not recommended.

How to administer Wegovy

Wegovy is administered as an injection under the skin (subcutaneous injection). Do not inject it into a vein or muscle.

  • The best areas for injection are the front of the upper arm, the top of the thighs, or the stomach.
  • Before using the pen for the first time, your doctor, pharmacist, or nurse will show you how to use it.

On the other side of this leaflet, you will find detailed instructions on how to use the pen.

People with type 2 diabetes

Tell your doctor if you have type 2 diabetes. Your doctor may adjust the dose of your diabetes medication to avoid low blood sugar.

When to use Wegovy

  • You should use this medicine once a week, and if possible, on the same day of the week.
  • The injection can be given at any time of day, regardless of meals.

If necessary, you can change the day of the weekly injection of this medicine, as long as at least 3 days have passed since the last injection. Once you have selected a new injection day, you should continue with the weekly dosing schedule.

If you use more Wegovy than you should

Talk to your doctor immediately. You may experience side effects such as nausea, vomiting, or diarrhea, which can cause dehydration (loss of fluids).

If you forget to use Wegovy

If you forget to inject a dose and:

  • it has been 5 days or less since you should have used Wegovy, use it as soon as you remember. Then, inject the next dose as usual, on the scheduled day.
  • it has been more than 5 days since you should have used Wegovy, skip the missed dose. Then, inject the next dose as usual, on the next scheduled day.

Do not give a double dose to make up for forgotten doses.

If you stop using Wegovy

Do not stop using this medicine without talking to your doctor.

If you have any other questions about the use of this medicine, ask your doctor, pharmacist, or nurse.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

Serious side effects

Common(may affect up to 1 in 10 people)

  • Complications of diabetic eye disease (diabetic retinopathy). If you have diabetes, you should tell your doctor if you experience eye problems, such as changes in vision, during treatment with this medicine.

Uncommon(may affect up to 1 in 100 people)

  • Pancreatitis (acute pancreatitis). Symptoms of pancreatitis can include severe and persistent stomach pain, which can radiate to the back. If you experience such symptoms, go to the doctor immediately.

Rare(may affect up to 1 in 1,000 people)

  • Severe allergic reactions (anaphylactic reactions, angioedema). You should seek medical help and tell your doctor immediately if you experience symptoms such as difficulty breathing, swelling, dizziness, rapid heartbeat, sweating, and loss of consciousness or rapid swelling under the skin in areas such as the face, throat, arms, and legs, which can be potentially fatal if the swelling of the throat blocks the airways.

Frequency not known(cannot be estimated from the available data)

  • Intestinal obstruction. A severe form of constipation with other symptoms such as stomach pain, abdominal swelling, vomiting, etc.

Other side effects

Very common(may affect more than 1 in 10 people)

  • headache
  • nausea
  • vomiting
  • diarrhea
  • constipation
  • stomach pain
  • feeling weak or tired
  • these are mainly seen during dose escalation and usually disappear over time.

Common(may affect up to 1 in 10 people)

  • feeling dizzy
  • stomach upset or indigestion
  • belching
  • gas (flatulence)
  • stomach swelling
  • inflamed stomach (gastritis); symptoms include stomach pain, nausea, or vomiting
  • reflux or heartburn; also called "gastroesophageal reflux disease"
  • gallstones
  • hair loss
  • reactions at the injection site
  • change in taste of food or drink
  • change in skin sensation
  • low blood sugar (hypoglycemia) in patients with type 2 diabetes.

The warning signs of low blood sugar may appear suddenly. They can include cold sweat, pale and cold skin, headache, rapid heartbeat, nausea, or excessive hunger, changes in vision, drowsiness, or feeling weak, nervousness, anxiety, or confusion, difficulty concentrating, or tremors.

Your doctor will tell you how to treat low blood sugar and what to do if you notice these warning signs.

It is more likely that your blood sugar will be low if you are also using a sulfonylurea or insulin. Your doctor may reduce the dose of these medicines before you start using this medicine.

Uncommon(may affect up to 1 in 100 people)

  • low blood pressure
  • feeling dizzy or lightheaded when standing up or sitting down due to a drop in blood pressure
  • rapid heartbeat
  • increased pancreatic enzymes (such as lipase and amylase) in blood tests
  • a delay in emptying the stomach.

Reporting of side effects

If you experience any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly through the national reporting system listed in Appendix V. By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storage of Wegovy

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the label of the pen and on the carton after "EXP". The expiry date is the last day of the month stated.

Before opening

Store in a refrigerator (between 2°C and 8°C). Do not freeze. Keep away from the cooling element of the refrigerator.

During use

  • The pen can be stored for 6 weeks if stored at a temperature not above 30°C or in a refrigerator (between 2°C and 8°C) away from the cooling element. Do not freeze Wegovy and do not use if it has been frozen.
  • When not in use, keep the pen cap on to protect it from light.

Do not use this medicine if you notice that the solution is not clear and colorless.

Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.

6. Container Contents and Additional Information

Composition of Wegovy

  • The active ingredient is semaglutide.

Wegovy 0.25 mg FlexTouch injectable solution

Each pre-filled pen contains 1 mg of semaglutide in 1.5 ml (0.68 mg/ml).

Wegovy 0.5 mg FlexTouch injectable solution

1.5 ml: each pre-filled pen contains 2 mg of semaglutide in 1.5 ml (1.34 mg/ml).

3 ml: each pre-filled pen contains 2 mg of semaglutide in 3 ml (0.68 mg/ml).

Wegovy 1 mg FlexTouch injectable solution

Each pre-filled pen contains 4 mg of semaglutide in 3 ml (1.34 mg/ml).

Wegovy 1.7 mg FlexTouch injectable solution

Each pre-filled pen contains 6.8 mg of semaglutide in 3 ml (2.27 mg/ml).

Wegovy 2.4 mg FlexTouch injectable solution

Each pre-filled pen contains 9.6 mg of semaglutide in 3 ml (3.2 mg/ml).

  • The other components are disodium phosphate dihydrate, propylene glycol, phenol, hydrochloric acid/sodium hydroxide (for pH adjustment), and water for injectable preparations. See also section 2 "Wegovy contains sodium" for more information on sodium.

Appearance of Wegovy and Container Contents

Wegovy is a clear and colorless injectable solution in a pre-filled pen.

Each pre-filled pen contains 4 doses.

Wegovy 0.25, 0.5, 1, and 1.7 mg FlexTouch injectable solution is available in the following package size:

1 pre-filled pen and 4 NovoFine Plus disposable needles.

Wegovy 2.4 mg FlexTouch injectable solution is available in the following package sizes:

1 pre-filled pen and 4 NovoFine Plus disposable needles.

3 pre-filled pens and 12 NovoFine Plus disposable needles

Not all package sizes may be marketed.

Marketing Authorization Holder

Novo Nordisk A/S

Novo Allé

DK-2880 Bagsværd

Denmark

Manufacturer

Novo Nordisk A/S

Novo Allé

DK-2880 Bagsværd

Denmark

Novo Nordisk Production SAS

45, Avenue d’Orléans

28000 Chartres

France

Date of Last Revision of this Leaflet:

Other Sources of Information

Detailed information on this medicinal product is available on the European Medicines Agency website: http://www.ema.europa.eu.

Instructions for Using the Wegovy Pen

Read these Instructions Carefullybefore starting to use your Wegovy FlexTouch pen weekly and consult your doctor, nurse, or pharmacist on how to inject Wegovy correctly.

The Wegovy pen is a dosing pen that contains your four prescribed doses of Wegovy, corresponding to the four weekly administrations.

Use the table found inside the outer packaging cover to keep track of how many injections you have used and how many doses are left in the pen.

Wegovy comes in five different pens, each containing one of the following prescribed doses of semaglutide:

Medication dose shown in a dark blue rectangle with white text indicating 0.25 mgMedication dose shown in a blue rectangle with white text indicating 0.5 mgBlue rectangular tablet with textMedication dose shown in white numbers on a dark blue background indicating 1.7 mgMedication dose shown in white numbers on a dark blue background indicating 2.4 mg

Always Check the Pen Labelto ensure it contains the prescribed dose of Wegovy.

Your pen is designed to be used with 30G, 31G, and 32G disposable needles up to 8 mm in length.

The Package Contains:

  • Wegovy pen
  • 4 NovoFine Plus needles
  • Leaflet

Wegovy FlexTouch pen with details of its parts: cap, pen window, dosing button, dose selector, and transparent needle

Novofine Plus needle showing outer cap, inner cap, body length, and paper tip

1 Prepare the Pen with a New Needle

Check the Name and Concentrationof your pen to ensure it contains the prescribed dose of Wegovy.

Remove the Pen Cap.

(See Figure A).

Hands holding a cylindrical device with a gray ring and a blue arrow indicating direction

Check that the Solution in Your Pen is Clear and Colorless.

Look through the pen window. If Wegovy appears cloudy or discolored, do not use the pen.

(See Figure B).

Pre-filled pen with transparent cartridge showing visible dose level and needle protector at its end

Always Use a New Needle for Each Injection.

Take a Needlewhen you are ready to give the injection. Check that the paper tab and the outer cap of the needle are not damaged, which could affect sterility. If you find any damage, use a new needle.

Remove the Paper Tab.

(See Figure C).

White adapter with curved end being inserted into a connector with a blue arrow indicating direction

Place the Needle Straight onto the Pen. Screw it on until it is Secure.

(See Figure D).

Hand holding an auto-injector with a curved arrow indicating the direction of injection on the device

The Needle is Covered by Two Caps. You Must Remove Both Caps.

If you forget to remove both caps, you will not inject Wegovy.

Remove the Outer Needle Cap and Set it Aside.You will need it later to safely remove the needle from the pen.

Remove the Inner Needle Cap and Discard it.A drop of Wegovy may appear at the tip of the needle. You should continue to check the flow of Wegovy if you are using a new pen for the first time. See “Check the Flow with Each New Pen”.

Never use a bent or damaged needle. For more information on handling needles, see the section “About Needles”that follows these instructions.

(See Figure E).

Syringe adapter being connected to an auto-injector device with an arrow indicating the direction of insertion

Check the Flow with Each New Pen

If your Wegovy pen is already in use, go to “2 Selecting the Dose”.

Check the flow of Wegovy only before the first injection with each new pen.

Turn the dose selector until you see the flow check symbol ()

(See Figure F).

Injection device with screen showing 0 mg held by a hand with an arrow indicating rotation

Make sure the flow check symbol matches the dose indicator.

(See Figure G).

White medical patch with digital indicator showing the letter “U” and the initials “mg”

Check the Flow

Hold the pen with the needle pointing upwards.

Press and Hold the Dose Buttonuntil the dose counter returns to . The must match the dose indicator.

A drop of Wegovy should appear at the tip of the needle. This drop indicates that the pen is ready for use.

If a drop does not appear, check the flow again. This should only be done twice.

If a drop still does not appear, change the needle and check the flow again.

Do Not Use the Penif a drop of Wegovy still does not appear.

(See Figure H).

White pen injector with visible button held by a hand, gray arrow pointing upwards indicating direction

2 Selecting the Dose

Turn the dose selector until the dose counter stopsand shows the selected dose.

(See Figure I).

Pen injector with dose shown as 0mg held by a hand with an arrow indicating injection action

The dashed line () on the dose counter will guide you to your dose.

The dose selector clicks differently when turned forward, backward, or when passing the dose. You will hear a “click” each time you turn the dose selector. Do not count the pen clicks.

(See Figure J).

Silver auto-injector device with a blue arrow pointing upwards and the legend “Dashed line” below

When the Selected Dose Matches the Dose Indicator, You Have Selected the Dose.In this image, the dose is shown as an example.

If the dose counter stops before reaching the prescribed dose, see the section “Do You Have Enough Wegovy?”that follows these instructions.

(See Figure K).

Pen injector with dose of 0.25mg shown between fingers with an arrow indicating direction of injection

Choose the Injection Site

Choose the upper arm, upper thigh, or stomach (keeping a distance of 5 cm from the navel).

You can inject in the same body area each week, but make sure it is not in the same spot you used last time.

Human body diagram with marked areas on shoulders, arms, chest, and legs indicating application sites

3 Injecting the Dose

Insert the Needle Under the Skin.

Make Sure You Can See the Dose Counter.Do not touch the dose counter with your fingers. This could interrupt the injection.

(See Figure L).

Hand holding a pen injector with a window showing “0.25 mg” and a blue arrow pointing downwards

Press and Hold the Dose Buttonuntil appears on the dose counter.

(See Figure M).

Press and Hold the Dose Buttonwith the needle under the skin and count slowly to 6. The must match the dose indicator. You may hear or feel a click when the dose counter returns to .

(See Figure N).

Pre-filled cartridge with 0mg of medication in a white capsule with a gray border and silver background

White background with a shield shape showing blue text indicating to count slowly from 1 to 6

Remove the Needle from the Skin.If the needle is removed too early, a jet of Wegovy may come out of the needle tip, and the full dose may not be administered.

If blood appears at the injection site, press the area lightly to stop the bleeding.

You may see a drop of Wegovy on the needle tip after the injection. This is normal and does not affect the dose.

(See Figure O).

Pre-filled pen with exposed needle pointing upwards with a blue arrow indicating direction of injection

4 After the Injection

Insert the Needle Tip into the Outer Needle Capon a flat surface without touching the needle or the outer needle cap.

When the Needle is Covered,carefully press the outer needle cap fully.

(See Figure P).

Needle connecting to a medication administration device with blue arrows indicating the direction of connection

Unscrew the Needleand carefully dispose of it according to the doctor's, nurse's, pharmacist's, or local authorities' instructions.

Never Attempt to Put the Inner Needle Cap Back On,as you could prick yourself with it.

Always Dispose of the Needle Immediately After Each Injectionto avoid needle obstruction, contamination, infection, and incorrect dosing. Never Store the Pen with the Needle Attached.

(See Figure Q).

Syringe needle with white tip being inserted into a transparent protective container with a blue arrow indicating direction

Put the Pen Cap Back Onafter each use to protect Wegovy from light.

(See Figure R).

Connection of a transparent cylindrical cartridge to a pen applicator with a blue arrow indicating direction

When the pen is empty, dispose of it without a needle, following the doctor's, nurse's, pharmacist's, or local authorities' instructions.

The pen cap and empty box can be discarded in household trash.

About Needles

How to Identify a Blocked or Damaged Needle

  • If does not appear on the dose counter after pressing the dose button several times, you may have used a blocked or damaged needle.
  • In that case, you have not receivedWegovy, even if the dose counter has moved from the original dose you selected.

How to Proceed with a Blocked Needle

  • Change the needle as indicated in “1 Prepare the Pen with a New Needle”and proceed to “2 Selecting the Dose”.

Maintenance of the Pen

Treat your pen with care. Rough handling or misuse can cause inaccurate dosing. If this happens, you may not get the desired effect of Wegovy.

  • Consult the back of this leaflet for the storage conditions of the pen.
  • Do Not Inject Wegovy that Has Been Exposed to Direct Sunlight.
  • Do Not Expose Wegovy to Cold and Never Inject Wegovy that Has Been Frozen.Discard the pen.
  • Do Not Drop the Penor hit it against hard surfaces.
  • Do Not Attempt to Refill the Pen.Once empty, discard it.
  • Do Not Attempt to Repair the Penor disassemble it.
  • Do Not Expose the Pen to Dust, Dirt, or Liquids.
  • Do Not Wash, Wet, or Lubricate the Pen.If necessary, clean it with a damp cloth and a mild detergent.

Do You Have Enough Wegovy?

If the dose counter stops before reaching the prescribed dose, there is not enough Wegovy for a full dose. Discard the pen and use a new Wegovy pen.

Injection device with dose marked as “1mg” held by fingers, showing the release button pressed

Important Information

  • Wegovy Should Only Be Injected Once a Week.If you do not use Wegovy as prescribed, you may not get the desired effect of this medication.
  • If you use more than one type of injectable medication, it is very important that you check the name and dose on the pen label before using it.
  • Do Not Use this Pen Without Helpif you have vision problems and cannot follow these instructions. Ask for help from someone who can see well and is trained in the use of the Wegovy pen.
  • Always keep the pen and needles out of sight and reach of other people, especially children.
  • Never Sharethe pen or needles with other people.
  • Needles are for Single Use. Never Reuse Them, as this can cause needle obstruction, contamination, or infection and incorrect dosing.
  • People caring for patients should handle used needles with great careto reduce the risk of accidental needlestick injuries and infections.

Get updates and exclusive offers

Be the first to know about new services, marketplace updates, and subscriber-only promos.

Follow us on social media
FacebookInstagram
Logo
Oladoctor
Find a doctor
Doctors by specialty
Services
Choose language
© 2025 Oladoctor. All rights reserved.
VisaMastercardStripe